Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Implant Therapeutics develops genetically engineered, hypoimmunogenic iPSC-derived mesenchymal stromal cells and islet cells incorporating panCELLa FailSafe and Stealth/iACT safety platforms for use as universal off‑the‑shelf therapeutic cells and ex vivo gene therapy vehicles; public information indicates preclinical development and technology-evaluation partnerships but no disclosed clinical trial results yet.[1][2][3][4][5][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Implant Therapeutics.